Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-06-06 | 2022-08-11 | 162080 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-07-11 | 2022-08-11 | 164370 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
APO-DASATINIB | 70MG | TABLET | Resolved | 2022-07-19 | 2022-08-12 | 164882 |
APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-11 | 2022-08-12 | 164378 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2022-07-22 | 2022-08-12 | 165326 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-06-27 | 2022-08-12 | 163453 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-07-15 | 2022-08-12 | 164741 |
APO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166589 |
APO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166592 |
APO-CANDESARTAN | 16MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166595 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-07-11 | 2022-08-19 | 164373 |
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2022-06-06 | 2022-08-22 | 162077 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2022-07-11 | 2022-08-22 | 164367 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2022-04-08 | 2022-08-24 | 158348 |
APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164710 |
APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-06-27 | 2022-08-24 | 163448 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-08-19 | 2022-08-24 | 167416 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164744 |
APO-ABIRATERONE FILM COATED TABLETS | 500MG | TABLET | Resolved | 2022-07-22 | 2022-08-26 | 165311 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |